BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10399506)

  • 1. [Low molecular weight heparin in unstable angina and myocardial infarction without Q wave].
    Choussat R; Montalescot G
    Presse Med; 1999 Jun; 28(21):1128-34. PubMed ID: 10399506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of heparin in unstable angina and non-Q-wave infarction].
    Choussat R; Attali P;
    Arch Mal Coeur Vaiss; 2001 Jan; 94(1):62-70. PubMed ID: 11233483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non-Q-wave acute myocardial infarction.
    Monrad ES
    Am J Cardiol; 2000 Apr; 85(8A):2C-9C. PubMed ID: 10793174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of low-molecular-weight heparin in acute coronary syndromes].
    Gharbi M; Barakett N; Lahidheb DH; Smiri Z; Fehri W; Azzouzi F; Rahal N; Mhenni H; Haouala H; Guediche M
    Tunis Med; 2002 Dec; 80(12):725-32. PubMed ID: 12664498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparins and unstable angina--current perspectives.
    Turpie AG
    Haemostasis; 1997; 27 Suppl 1():19-24. PubMed ID: 9439754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice].
    Ottani F; Ferrini D; Di Pasquale G; Galvani M
    Ital Heart J Suppl; 2001 Sep; 2(9):958-71. PubMed ID: 11675833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparins and coronary artery disease.
    Zed PJ
    Curr Cardiol Rep; 2000 Jan; 2(1):61-8. PubMed ID: 10980874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New frontiers in the management of unstable coronary artery disease.
    Turpie AG
    Am J Cardiol; 1997 Sep; 80(5A):21E-24E. PubMed ID: 9296465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).
    Klein W; Buchwald A; Hillis SE; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
    Circulation; 1997 Jul; 96(1):61-8. PubMed ID: 9236418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulants in acute coronary syndromes.
    Turpie AG
    Am J Cardiol; 1999 Sep; 84(5A):2M-6M. PubMed ID: 10505536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparins in the management of unstable angina/non-Q-wave myocardial infarction.
    Cohen M
    Semin Thromb Hemost; 1999; 25 Suppl 3():113-21. PubMed ID: 10549726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low molecular weight heparins in acute coronary syndrome].
    Huber K; Niessner A; Niessner H
    Herz; 2001 Apr; 26 Suppl 1():53-60. PubMed ID: 11349628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparin in unstable coronary artery disease.
    Wallentin L
    Expert Opin Investig Drugs; 2000 Mar; 9(3):581-92. PubMed ID: 11060697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of low-molecular-weight heparin in acute coronary syndromes.
    Fiorini DM
    AACN Clin Issues; 2001 Feb; 12(1):53-61. PubMed ID: 11288329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?
    Kaul S; Shah PK
    J Am Coll Cardiol; 2000 Jun; 35(7):1699-712. PubMed ID: 10841215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin and dalteparin in unstable angina: new indication. Enoxaparin: a reference treatment. Dalteparin: no better than unfractionated heparin.
    Prescrire Int; 1999 Jun; 8(41):77-80. PubMed ID: 10558446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxaparin. A review of its clinical potential in the management of coronary artery disease.
    Noble S; Spencer CM
    Drugs; 1998 Aug; 56(2):259-72. PubMed ID: 9711450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.
    Turpie AG
    Can J Cardiol; 1998 Aug; 14 Suppl E():20E-23E. PubMed ID: 9779029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease.
    Husted S; Kher A
    Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.